Clinical, Pharmacologic and Device Trials

BASIC RESEARCH
PUBLICATIONS

For more information regarding these studies, call 414-649-3356.

Atherosclerotic Disease

TRA-2P
Study Sponsor: Schering Plough Research Institute
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events
Principal Investigator: Anjan Gupta, MD
Clinical Coordinator: Deb Seaton, RN

CRESCENDO
Study Sponsor: sanofi-aventis
Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20 mg OD for reducing the risk of major cardiovascular events in abdominally obese patients with clustering risk factors
Principal Investigator: Dianne Zwicke, MD
Clinical Coordinator: Deb Seaton, RN

Atrial Septal Defects/Patent Foramen Ovale/Migraines

PREMIUM (PFO-Patent Foramen Ovale Closure for migraine headaches)
Study Sponsor: AGA Medical Corporation
Prospective Randomized investigation to Evaluate incidence of headache reduction in patients with Migraine and PFO Using the AMPLATZER PFO Occluder compared to Medical Management
Principal Investigator: Tanvir Bajwareturn to top of page